Surgery Partners, Inc. (NASDAQ:SGRY) Q4 2024 Earnings Call Transcript
Operator: Greetings. Welcome to Surgery Partners, Inc. Fourth Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
Surgery Partners Inc. (SGRY)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Alpine Associates Robert Emil Zoellner | 570,075 | $13,539,281 | 0.71% | |
| 2. | Kintayl Capital John Mcanearney | 164,321 | $3,902,624 | 2.76% | |
| 3. | 100,000 | $2,375,000 | 1.68% | ||
| 4. | Bayforest Capital Theodoros Tsagaris | 42,803 | $512,406 | 0.42% | |
| 5. | Sivik Global Healthcare Krishen Sud | 125,000 | $2,969 | -38% | 1.61% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.50 | 10,000 | Director | 57,701 | 2022-11-21 | Filing | |
| $24.50 | 20,000 | Director | 47,968 | 2022-11-21 | Filing | |
| $46.70 | 2,000 | Director | 25,473 | 2021-08-10 | Filing | |
| $6.65 | 1,000 | Director | 27,459 | 2019-09-06 | Filing | |
| $6.00 | 25,000 | Officer | 71,928 | 2019-08-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $23.94 | 612 | Officer | 236,047 | 2025-03-14 | Filing | |
| $23.78 | 74 | Officer | 44,839 | 2025-03-14 | Filing | |
| $23.70 | 138 | Officer | 74,521 | 2025-03-14 | Filing | |
| $24.16 | 4,045 | Officer | 126,520 | 2025-03-10 | Filing | |
| $23.97 | 3,008 | Officer | 236,659 | 2025-03-10 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,166,713 | $170,209,434 | 0% | |
| 2. | 6,173,007 | $146,608,912 | 0% | |
| 3. | 1,085,959 | $25,791,526 | 0.69% | |
| 4. | 890,816 | $21,156,880 | 0% | |
| 5. | 870,670 | $20,678,413 | 0.02% |
News See All
Surgery Partners, Inc. (NASDAQ:SGRY) Q3 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Surgery Partners Third Quarter 2024 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
Surgery Partners, Inc. (NASDAQ:SGRY) Q2 2024 Earnings Call Transcript
Operator: Good day, everyone, and welcome to today’s program, Surgery Partners, Inc. Second Quarter 2024 Earnings Call. At this time all participants are in a listen-only mode.
Here’s Why Surgery Partners (SGRY) Sold Off in Q1
ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” first quarter 2024 investor letter. A copy of the letter can be downloaded here.
Surgery Partners, Inc. (NASDAQ:SGRY) Q1 2024 Earnings Call Transcript
Surgery Partners, Inc. beats earnings expectations. Reported EPS is $0.2628, expectations were $0.07.
Should You Invest in Surgery Partners (SGRY)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.
Surgery Partners, Inc. (NASDAQ:SGRY) Q4 2023 Earnings Call Transcript
Surgery Partners, Inc. beats earnings expectations. Reported EPS is $0.44, expectations were $0.37. Surgery Partners, Inc.
Jim Cramer Says Do Not Buy These 11 Stocks
Jim Cramer continues to challenge the market bears after NVIDIA Corp (NASDAQ:NVDA) smashed the Wall Street estimates with another stunning quarter, essentially proving that the AI rally that kept giving...
Jim Cramer Says You Should Stay Away from These 10 Stocks
In this article, we will take a detailed look at the Jim Cramer Says You Should Stay Away from These 10 Stocks. For a quick overview of such stocks, read our article Jim Cramer Says You Should Stay...
Is Surgery Partners (SGRY) a Good Long-Term Stock?
Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
Billionaire Hedge Funds
